featured
2016 Top Stories in Dermatology: Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Eggermont AMM, Chiarion-Sileni V, Grob J-J, et al. Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC18071): a randomized, double blind, phase 3 trial. Lancet Oncol. 2015;16(5):522-530
- Baksh K, Weber J. Immune checkpoint protein inhibition for cancer: preclinical justification for CTLA-4 and PD-1 blockade and new combinations. Semin Oncol. 2015;42(3):363-377.
- Kaisaki PJ, Cutts A, Popitsch N, et al. Targeted next-generation sequencing of plasma DNA from cancer patients: factors influencing consistency with tumour DNA and prospective investigation of its utility for diagnosis. PLoS One. 2016;11(9):e0162809.
Disclosure statements are available on the authors' profiles: